SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
AMENDMENT NO. 27
TO
SCHEDULE 13D
Under the Securities Exchange Act of 1934
Circon Corporation
(Name of Issuer)
Common Stock, $.01 par value
(Title of Class of Securities)
172736100
(CUSIP Number)
Mark H. Swartz
Executive Vice President
c/o Tyco International (US) Inc.
One Tyco Park
Exeter, NH 03833
(603) 778-9700
Abbe L. Dienstag, Esq.
Kramer, Levin, Naftalis & Frankel
919 Third Avenue
New York, NY 10022
(212) 715-9100
(Name, Address and Telephone Number of
Person Authorized to Receive Notices
and Communications)
October 1, 1998
(Date of Event which Requires Filing
of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box: [_]
Page 1 of 14 pages
Exhibit Index appears on Page 7.
<PAGE>
SCHEDULE 13D
CUSIP No. 172736700 Page 2 of 14 Pages
- --------------------------------------------------------------------------------
1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Tyco International Ltd.
- --------------------------------------------------------------------------------
2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [X]
(b) [_]
- --------------------------------------------------------------------------------
3) SEC USE ONLY
- --------------------------------------------------------------------------------
4) SOURCE OF FUNDS
AF
- --------------------------------------------------------------------------------
5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e) [_]
- --------------------------------------------------------------------------------
6) CITIZENSHIP OR PLACE OF ORGANIZATION
Bermuda
- --------------------------------------------------------------------------------
7) SOLE VOTING POWER
NUMBER OF Not applicable.
SHARES --------------------------------------------------------------
BENEFICIALLY 8) SHARED VOTING POWER
OWNED BY
EACH REPORTING 1,959,348 (See Item 5)
PERSON --------------------------------------------------------------
WITH 9) SOLE DISPOSITIVE POWER
Not applicable.
--------------------------------------------------------------
10) SHARED DISPOSITIVE POWER
1,959,348 (See Item 5)
- --------------------------------------------------------------------------------
11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,959,348 (See Item 5)
- --------------------------------------------------------------------------------
12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES [_]
- --------------------------------------------------------------------------------
13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
14.6% (See Item 5)
- --------------------------------------------------------------------------------
14) TYPE OF REPORTING PERSON
CO
- --------------------------------------------------------------------------------
<PAGE>
SCHEDULE 13D
CUSIP No. 172736700 Page 3 of 14 Pages
- --------------------------------------------------------------------------------
1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
United States Surgical Corporation
- --------------------------------------------------------------------------------
2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [X]
(b) [_]
- --------------------------------------------------------------------------------
3) SEC USE ONLY
- --------------------------------------------------------------------------------
4) SOURCE OF FUNDS
AF/WC
- --------------------------------------------------------------------------------
5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e) [_]
- --------------------------------------------------------------------------------
6) CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- --------------------------------------------------------------------------------
7) SOLE VOTING POWER
NUMBER OF Not applicable.
SHARES --------------------------------------------------------------
BENEFICIALLY 8) SHARED VOTING POWER
OWNED BY
EACH REPORTING 1,959,348 (See Item 5)
PERSON --------------------------------------------------------------
WITH 9) SOLE DISPOSITIVE POWER
Not applicable.
--------------------------------------------------------------
10) SHARED DISPOSITIVE POWER
1,959,348 (See Item 5)
- --------------------------------------------------------------------------------
11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,959,348 (See Item 5)
- --------------------------------------------------------------------------------
12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES [_]
- --------------------------------------------------------------------------------
13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
14.6% (See Item 5)
- --------------------------------------------------------------------------------
14) TYPE OF REPORTING PERSON
CO
- --------------------------------------------------------------------------------
<PAGE>
SCHEDULE 13D
CUSIP No. 172736700 Page 4 of 14 Pages
- --------------------------------------------------------------------------------
1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
USS Acquisition Corp.
- --------------------------------------------------------------------------------
2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [X]
(b) [_]
- --------------------------------------------------------------------------------
3) SEC USE ONLY
- --------------------------------------------------------------------------------
4) SOURCE OF FUNDS
AF/WC
- --------------------------------------------------------------------------------
5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e) [_]
- --------------------------------------------------------------------------------
6) CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- --------------------------------------------------------------------------------
7) SOLE VOTING POWER
NUMBER OF Not applicable.
SHARES --------------------------------------------------------------
BENEFICIALLY 8) SHARED VOTING POWER
OWNED BY
EACH REPORTING 973,174 (See Item 5)
PERSON --------------------------------------------------------------
WITH 9) SOLE DISPOSITIVE POWER
Not applicable.
--------------------------------------------------------------
10) SHARED DISPOSITIVE POWER
973,174 (See Item 5)
- --------------------------------------------------------------------------------
11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
973,174 (See Item 5)
- --------------------------------------------------------------------------------
12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES [_]
- --------------------------------------------------------------------------------
13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
7.3% (See Item 5)
- --------------------------------------------------------------------------------
14) TYPE OF REPORTING PERSON
CO
- --------------------------------------------------------------------------------
<PAGE>
Schedule 13D
Tyco International Ltd., a Bermuda company ("Tyco"), United States
Surgical Corporation, a Delaware corporation and an indirect wholly owned
subsidiary of Tyco("US Surgical"), and USS Acquisition Corp, a Delaware
corporation and a wholly owned subsidiary of US Surgical ("USS") hereby further
amend and supplement Statement on Schedule 13D previously filed by US Surgical
and USS (the "Schedule 13D") relating to the common stock, $.01 par value (the
"Common Stock"), of Circon Corporation, a Delaware coporation (the
"Issuer"),originally filed with the Securities and Exchange Commission (the
"Commission") on August 2, 1996, as amended. The item numbers and responses
thereto below are in accordance with the requirements of Schedule 13D.
Unless otherwise indicated herein, each capitalized term used but not
defined herein shall have the meaning assigned to such term in the Schedule 13D.
The term Reporting Persons means each of Tyco, US Surgical and USS.
Item 2. Identity and Background.
Item 2 is hereby amended and supplemented by adding the following
infomation with respect to Tyco as follows:
(a)-(c) Tyco's registered offices are located at The Gibbons Building, 10 Queen
Street, Hamilton HM11 Bermuda, and its telephone number is (441) 292-8674. The
executive offices of Tyco International (US) Inc., Tyco's principal United
States subsidiary, are located at One Tyco Park, Exeter, New Hampshire 03833,
and its telephone number is (603) 778-9700.
Tyco is a diversified manufacturing and service company that, through
its subsidiaries, operates in four segments: (i) the manufacture and
distribution of disposable medical supplies and other specialty products, and
the conduct of vehicle auctions and related services; (ii) the design,
manufacture, installation and service of fire detection and suppression systems,
and the installation, monitoring and maintenance of electronic security systems;
(iii)the design, manufacture and distribution of flow control products; and (iv)
the design, manufacture and distribution of electrical and electronic
components, and the design, manufacture, installation and service of undersea
cable communication systems.
The name, business address and present principal occupation or
employment of each of the executive officers and directors of Tyco, are set
forth on Schedule II annexed hereto, which is incorporated herein by reference.
Page 5 of 14
<PAGE>
(d) - (e) During the last five years, none of Tyco, and, to the best
knowledge of Tyco, none of the persons listed on Schedule II hereto, has been
convicted in a criminal proceeding (excluding traffic violations and similar
misdemeanors) or has been a party to a civil proceeding of a judicial or
administrative body of competent jurisdiction and as a result of such proceeding
was or is subject to a judgment, decree or final order enjoining future
violations of, or prohibiting or mandating activities subject to, Federal or
state securities laws or finding any violation with respect to such laws.
(f) Except as indicated on Schedule II each natural person identified
in this amendment to Item 2 is a citizen of the United States.
Item 3. Source and Amount of Funds or Other Consideration.
Item 3 is hereby amended and supplemented by adding the following
infomation with respect to Tyco as follows as follows:
Tyco acquired its beneficial ownership in the Common Stock of the
Issuer as a result of the consummation, on October 1, 1998, of the merger (the
"Tyco/US Surgical Merger") of US Surgical with a subsidiary of Tyco. In the
merger, each share of common stock of US Surgical was exchanged for 0.7606
common shares of Tyco.
Item 4. Purpose of Transaction.
Item 4 is hereby amended and supplemented by adding the following
infomation with respect to Tyco as follows as follows:
At the invitation of the Issuer and following the conduct of certain
due diligence investigations, in September 1998 Tyco submitted a bid for the
acquisition of the Issuer by Tyco. That bid has been rejected by the Issuer.
Item 5. Interest in Securities of the Issuer.
Item 5 is hereby amended as follows:
(a) As of the date hereof, the Reporting Persons beneficially own an
aggregate of 1,959,348 shares of Common Stock of the Issuer (the "Shares").
Based upon publicly available information, such Shares represent approximately
14.6% of the outstanding Shares./1/
Page 6 of 14
- --------
/1/ As of June 30, 1998, 13,396,794 Shares were outstanding.
<PAGE>
(b) The Reporting Persons share the power to vote or to direct the vote, and
share the power to dispose or to direct the disposition, of the Shares held by
them.
(c) Other than the indirect acquisition of the shares of Common Stock by Tyco as
a result of the Tyco/US Surgical Merger, none of the Reporting Persons has
effected any transactions in the class of securities reported.
(d) Not applicable.
(e) Not applicable.
Item 6. Contracts, Arrangements, Understandings or
Relationships with Respect to Securities of the Issuer.
Item 6 is hereby amended and supplemented by adding the following
infomation with respect to Tyco as follows as follows:
In connection with Tyco's due diligence investigation referred to in
Item 4, a subsidiary of Tyco entered into a confidentiality agreement for the
benefit of the Issuer.
Item 7. Material to be Filed as Exhibits.
Item 7 of the Schedule 13D is hereby amended and supplemented by the
following:
Exhibit 1. Agreement of Joint Filing pursuant to Rule 13d- 1(k)(l)
promulgated under the Securities Exchange Act of 1934, as
amended.
Page 7 of 14
<PAGE>
SIGNATURE
After reasonable inquiry and to the best knowledge and belief of the
undersigned, the undersigned certifies that the information set forth in this
Statement is true, complete and correct.
Dated: October 13, 1998
TYCO INTERNATIONAL LTD.
/s/ Mark H. Swartz
------------------
By: Mark H. Swartz
Executive Vice President &
Chief Financial Officer
Page 8 of 14
<PAGE>
SIGNATURE
After reasonable inquiry and to the best knowledge and belief of the
undersigned, the undersigned certifies that the information set forth in this
Statement is true, complete and correct.
Dated: October 13, 1998
UNITED STATES SURGICAL CORPORATION
/s/ Mark H. Swartz
-------------------------
By: Mark H. Swartz
Vice President
Page 9 of 14
<PAGE>
SIGNATURE
After reasonable inquiry and to the best knowledge and belief of the
undersigned, the undersigned certifies that the information set forth in this
Statement is true, complete and correct.
Dated: October 13, 1998
USS Acquisition Corp.
/s/ Mark H. Swartz
-----------------------
By: Mark H. Swartz
Vice President
Page 10 of 14
<PAGE>
SCHEDULE II
EXECUTIVE OFFICERS AND DIRECTORS
The name and present principal occupation or employment of each of the executive
officers and directors of Tyco International Ltd. ("Tyco") are set forth below.
Name and Position Current Business Present Principal
Held Address Occupation or
Employment
L. Dennis c/o Tyco Chairman of the
Kozlowski, International (US) Board, President
Chairman of the Inc. ("Tyco (US)") and Chief
Board, President & One Tyco Park Executive Officer
Chief Executive Exeter, NH 03833 of Tyco.
Officer
Michael A. P.O. Box 1598 Non-executive
Ashcroft, Belize City, Chairman of BHI
Director Belize Corporation
(citizen of
Belize)
Joshua M. Berman, 919 Third Avenue Counsel to the law
Director and Vice New York, NY 10022 firm of Kramer,
President Levin, Naftalis &
Frankel
Richard S. Bodman, 2 Wisconsin Circle Managing General
Director Suite 610 Partner of AT&T
Chevy Chase, MD Ventures LLC
20815
John F. Fort, III, 2003 Milford St. Director of Tyco
Director Houston, TX 77098
Steven W. Foss, 380 Lafayette Rd. President of Foss
Director Hampton, NH 03842 Manufacturing
Company, Inc.
Richard A. 2829 Townsgate Rd. President of Tyco
Gilleland, Suite 101 Healthcare
Director West Lake Village, Products Group
CA 91361
Page 11 of 14
Name and Position Current Business Present Principal
Held Address Occupation or
Employment
Phillip M. 152 West 57th St. Co-Managing
Hampton, 44th Floor Director of R. H.
Director New York, NY 10019 Arnold & Co.
James S. Pasman, 29 The Trillium Director of Tyco
Jr. Pittsburgh, PA
Director 15238
W. Peter Slusser, One Citicorp President of
Director Center Slusser
Suite 5100 Associates, Inc.
153 East 53rd St.
New York, NY 10022
Frank E. Walsh, 330 South Street Chairman of
Jr., Morristown, NJ Sandyhill
Director 07962-1975 Foundation
Jerry R. Boggess, c/o Tyco (US) Vice President of
Vice President of Three Tyco Park Tyco (US)
Tyco (US) Exeter, NH 03833
David P. Brownell, c/o Tyco (US) Senior Vice
Senior Vice 1750 Clintmore Rd. President of Tyco
President P.O. Box 5034 (US)
Boca Raton, FL
33431
Robert P. Mead, c/o Tyco (US) Vice President of
Vice President of Three Tyco Park Tyco (US)
Tyco (US) Exeter, NH 03833
Richard J. Meelia, 15 Hampshire St. Vice President of
Vice President of Mansfield, MA Tyco (US)
Tyco (US) 02048
Mark H. Swartz, c/o Tyco (US) Executive Vice
Executive Vice One Tyco Park President & Chief
President & Chief Exeter, NH 03833 Financial Officer
Financial Officer of Tyco
Page 12 of 14
Name and Position Current Business Present Principal
Held Address Occupation or
Employment
Mark A. Belnick, c/o Tyco (US) Executive Vice
Executive Vice 712 Fifth Avenue President & Chief
President & Chief 48th Floor Corporate Counsel
Corporate Counsel New York, NY 10019 of Tyco
Page 13 of 14
Exhibit 1
Agreement of Joint Filing
Pursuant to 13d-1(k)(l) promulgated under the Securities Exchange
Act of 1934, as amended, the undersigned persons hereby agree to file with the
Securities and Exchange Commission the Statement on Schedule 13D (the
"Statement") to which this Agreement is attached as an exhibit, and agree that
such Statement, as so filed, is filed on behalf of each of them.
IN WITNESS WHEREOF, the undersigned have executed this Agreement.
TYCO INTERNATIONAL LTD.
/s/ Mark H. Swartz
------------------
By: Mark H. Swartz
Executive Vice President &
Chief Financial Officer
UNITED STATES SURGICAL
CORPORATION
/s/ Mark H. Swartz
------------------
By: Mark H. Swartz
USS ACQUISITION CORP.
/s/ Mark H. Swartz
------------------
By: Mark H. Swartz
Vice President
Page 14 of 14
